Presentation of the top five nutraceuticals from red meat to the PFIAA

Summary

• Increasingly, people are using nutraceuticals as adjuncts to conventional medical therapies and expect the same options for their pets.
• Pets are living longer and are thus more likely to develop old-age diseases such as osteoarthritis and obesity.
• The most common canine and feline diseases for which red meat-derived nutraceuticals are used are osteoarthritis and obesity.
  Many common diseases of cats and dogs are not managed using nutraceuticals.
• The most common red meat-derived nutraceuticals in pet foods are:
  • Glucosamine
  • Chondroitin sulphate
  • Pentosan polysulphate
  • L-carnitine
  • Taurine
  • Arginine
• Nutraceuticals in pet foods are derived from :
  • Red meat used in the manufacture of the food
  • Synthetic production
  • Poultry meal
• Yields from red meat and by-products are potentially high.
• Nutraceuticals included in pet foods do not require government registration in Australia or the USA, provided that no therapeutic claim to “prevent, treat, alleviate or cure” a disease is made.

Key findings

The nutraceutical & bioactive area has great opportunities to develop:

• Opportunities to increase production from red meat of commonly used nutraceuticals
• Opportunities to identify novel nutraceuticals and bioactives not currently used for pets
• Opportunities to identify novel nutraceuticals and bioactives not currently used for pets
• Requires identification of potential nutraceuticals & bioactives from work in other species
• Requires trials to demonstrate safety and clinical benefit (usually costly - $100-350K/year)